ASKER.ST Asker Healthcare
- Market cap
- SEK 29.1B
- P/E
- 38.8x
- P/B
- 3.96x
- ROE
- 11.5%
- Dividend yield
- 0.51%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ASKER.ST undervalued?
Graham numberASKER.ST trades 161.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Asker Healthcare fundamental analysis
No fundamental analysis for Asker Healthcare yet.
Asker Healthcare stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products fo…
Full company profileAsker Healthcare financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Asker Healthcare annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 9.35B | 11.7B | 13.5B | 15.0B | 16.8B | 18.6B |
| Gross Profit | 2.61B | 3.78B | 4.52B | 5.88B | 6.06B | 7.46B |
| Operating Income | 598M | 708M | 579M | 966M | 1.28B | 1.30B |
| EBITDA | 835M | 1.12B | 1.12B | 1.47B | 2.09B | 1.95B |
| Net Income | 467M | 430M | 203M | 360M | 492M | 841M |
| EPS | 1.22 | 1.12 | 0.53 | 0.94 | 1.34 | 2.15 |
| Balance Sheet | ||||||
| Total Assets | 7.36B | 10.2B | 11.3B | 13.1B | 16.8B | 18.9B |
| Total Liabilities | 5.54B | 7.44B | 8.29B | 9.62B | 10.2B | 11.6B |
| Shareholders' Equity | 1.79B | 2.76B | 3.02B | 3.47B | 6.56B | 7.31B |
| Cash & Short-term Investments | 494M | 211M | 391M | 490M | 884M | 801M |
| Total Debt | 3.93B | 4.74B | 4.97B | 5.96B | 5.81B | - |
| Cash Flow | ||||||
| Operating Cash Flow | 382M | 976M | 1.05B | 1.23B | 1.33B | 1.16B |
| Capital Expenditure | 124M | 123M | 151M | 348M | 590M | 431M |
| Free Cash Flow | 258M | 853M | 901M | 879M | 738M | 731M |
| Ratios | ||||||
| ROE | 26.1% | 15.6% | 6.7% | 10.4% | 7.5% | 11.5% |
| ROA | 6.3% | 4.2% | 1.8% | 2.7% | 2.9% | 4.5% |
| Net Profit Margin | 5.0% | 3.7% | 1.5% | 2.4% | 2.9% | 4.5% |
| Debt to Equity | 2.19x | 1.72x | 1.65x | 1.72x | 0.89x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Asker Healthcare dividends
- Dividend yield
- 0.51%
- Forward dividend
- 0.39 SEK
- Payout ratio
- -
- Ex-dividend date
- May 8, 2026
Who owns Asker Healthcare
- Insiders 4.07%
- Institutions 86.17%
- Public & others 9.76%
- Shares outstanding 383M
- Free float 228M
Asker Healthcare company profile
- Company name
- Asker Healthcare
- Ticker
- ASKER.ST
- ISIN
- SE0024171458
- Exchange
- Stockholm Exchange
- Sector
- Healthcare
- Industry
- Medical Distribution
- Employees
- 4,898
- Fiscal year end
- December
- Address
- SvÄRdvÄGen 3A, Danderyd, Sweden, 182 33
- Phone
- 46 8 55 60 11 00
- Website
- asker.com
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products. In addition, it develops and sells disposable medical supplies under the Evercare, Selefa, and Embra brands; distributes eye surgery products; and develops and sells products for time-management, communication, and cognition for schools, assistive technology centres, and other public services. Further, the company provides support and assistance to people needing wound, diabetes, and urological care; ostomy, urology, and rehab services; ambulance services; and products for physiotherapy practices, as well as supplies exercise and treatment equipment and measurement. Additionally, it sells and rents out various mobility aids and rehab products, such as pressure-relieving mattresses and cushions, as well as manufactures and distributes pressure care products. The company operates in Sweden, Norway, Finland, Estonia, Latvia, Lithuania, Netherlands, Belgium, Luxembourg, Denmark, the United Kingdom, Ireland, Germany, Austria, Switzerland, France, Slovakia, Czech Republic, and Poland. Asker Healthcare Group AB (publ) was founded in 2006 and is headquartered in Danderyd, Sweden.
Asker Healthcare management
7- Mr. Johan FalkChief Executive Officer · born 1971
- Mr. Thomas MossCFO & Head of Investor Relations · born 1973
- Ms. Jennie EspelundGeneral Counsel · born 1984
- Ms. Emma RheborgHead of Communication · born 1972
- Ms. Kerstin MjomarkHead of HR & ESG · born 1979
- Mr. Mattias JaranHead of IT Integrity · born 1972
- Ms. Lovisa HedinHead of M&A